Shin Y, Moussa M, Akwe J
J Brown Hosp Med. 2025; 3(3):120951.
PMID: 40026396
PMC: 11864428.
DOI: 10.56305/001c.120951.
Martinez C, Pla M, Feliu A, Enriquez M, Saura J, Cabezas C
Subst Abuse Treat Prev Policy. 2025; 20(1):3.
PMID: 39838401
PMC: 11752777.
DOI: 10.1186/s13011-024-00632-8.
Hahn A, Ruderman S, Nance R, Delaney J, Whitney B, Eltonsy S
Drug Alcohol Depend Rep. 2024; 13:100291.
PMID: 39555143
PMC: 11566314.
DOI: 10.1016/j.dadr.2024.100291.
Kim H, Kim Y, Lee Y, Yoo J, Choi Y, Kim E
Int J Biol Sci. 2024; 20(14):5450-5473.
PMID: 39494328
PMC: 11528454.
DOI: 10.7150/ijbs.97723.
Dempster E, Wong C, Burrage J, Hannon E, Quattrone D, Trotta G
Mol Psychiatry. 2024; .
PMID: 39406996
DOI: 10.1038/s41380-024-02689-0.
Impact of Pre-Adolescent Substance Familiarity on Subsequent Use: Longitudinal Analysis of Risk by Latent Classes in the Adolescent Brain Cognitive Development Sample.
Moore A, Lewis B, Farrior H, Hinckley J, Nixon S, Bhatia D
Subst Use Misuse. 2024; 60(1):1-11.
PMID: 39279127
PMC: 11663692.
DOI: 10.1080/10826084.2024.2403109.
[Procedures of complementary medicine in rheumatology].
Keysser G, Frohne I, Schultz O, Reuss-Borst M, Sander O, Pfeil A
Z Rheumatol. 2024; 83(7):549-561.
PMID: 38935116
DOI: 10.1007/s00393-024-01524-9.
Association of Cannabis Use Disorder With Hospitalizations for Pulmonary Embolism and Subsequent in-Hospital Mortality in Young Adults: A Contemporary Nationwide Analysis.
Desai R, Ghadge N, Kanagala S, Katukuri N, James A, Kadiyala A
J Am Heart Assoc. 2024; 13(13):e032787.
PMID: 38934855
PMC: 11255712.
DOI: 10.1161/JAHA.123.032787.
Development of Mobile Contingency Management for Cannabis Use Reduction.
Beckham J, Calhoun P, Chen Z, Dennis M, Kirby A, Treis E
Behav Ther. 2024; 55(1):1-13.
PMID: 38216224
PMC: 10787157.
DOI: 10.1016/j.beth.2023.03.004.
Adverse outcomes of cannabis use in Canada, before and after legalisation of non-medical cannabis: cross-sectional analysis of the International Cannabis Policy Study.
Marquette A, Iraniparast M, Hammond D
BMJ Open. 2024; 14(1):e077908.
PMID: 38171626
PMC: 10773397.
DOI: 10.1136/bmjopen-2023-077908.
Parallel trajectories of vaping and smoking cannabis and their associations with mental and physical well-being among young adults.
Dunbar M, Davis J, Tucker J, Seelam R, Rodriguez A, DAmico E
Drug Alcohol Depend. 2023; 251:110918.
PMID: 37611482
PMC: 10538384.
DOI: 10.1016/j.drugalcdep.2023.110918.
Cannabis- and Substance-Related Carcinogenesis in Europe: A Lagged Causal Inferential Panel Regression Study.
Reece A, Bennett K, Hulse G
J Xenobiot. 2023; 13(3):323-385.
PMID: 37489337
PMC: 10366890.
DOI: 10.3390/jox13030024.
"I still partly think this is bullshit": A qualitative analysis of cannabinoid hyperemesis syndrome perceptions among people with chronic cannabis use and cyclic vomiting.
Collins A, Beaudoin F, Metrik J, Wightman R
Drug Alcohol Depend. 2023; 246:109853.
PMID: 36996524
PMC: 10121940.
DOI: 10.1016/j.drugalcdep.2023.109853.
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
Pintori N, Caria F, De Luca M, Miliano C
Int J Mol Sci. 2023; 24(6).
PMID: 36982327
PMC: 10048857.
DOI: 10.3390/ijms24065251.
Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study.
Reece A, Hulse G
Pediatr Rep. 2023; 15(1):69-118.
PMID: 36810339
PMC: 9944887.
DOI: 10.3390/pediatric15010009.
Novel Insights into Potential Cannabis-Related Cancerogenesis from Recent Key Whole Epigenome Screen of Cannabis Dependence and Withdrawal: Epidemiological Commentary and Explication of Schrott et al.
Reece A, Hulse G
Genes (Basel). 2023; 14(1).
PMID: 36672773
PMC: 9858221.
DOI: 10.3390/genes14010032.
Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis.
Reece A, Hulse G
Int J Environ Res Public Health. 2022; 19(24).
PMID: 36554603
PMC: 9778714.
DOI: 10.3390/ijerph192416721.
Clinical Considerations for Cannabis Use and Cardiovascular Health.
Sajdeya R, Jugl S, Cook R, Brown J, Goodin A
Med Cannabis Cannabinoids. 2022; 5(1):120-127.
PMID: 36467784
PMC: 9710318.
DOI: 10.1159/000526731.
Validity of the Single-Item Screen-Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care.
Matson T, Lapham G, Bobb J, Oliver M, Hallgren K, Williams E
JAMA Netw Open. 2022; 5(11):e2239772.
PMID: 36318205
PMC: 9627408.
DOI: 10.1001/jamanetworkopen.2022.39772.
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions.
Henson J, Vitetta L, Hall S
Inflammopharmacology. 2022; 30(4):1167-1178.
PMID: 35796920
PMC: 9294022.
DOI: 10.1007/s10787-022-01020-z.
